ATE120648T1 - Schmerzstillendes und entzündungshemmendes pflaster. - Google Patents

Schmerzstillendes und entzündungshemmendes pflaster.

Info

Publication number
ATE120648T1
ATE120648T1 AT90125524T AT90125524T ATE120648T1 AT E120648 T1 ATE120648 T1 AT E120648T1 AT 90125524 T AT90125524 T AT 90125524T AT 90125524 T AT90125524 T AT 90125524T AT E120648 T1 ATE120648 T1 AT E120648T1
Authority
AT
Austria
Prior art keywords
reserver
drug
pain relieving
acid
inflammatory plaster
Prior art date
Application number
AT90125524T
Other languages
English (en)
Inventor
Akihito Oji
Yukihiro Tada
Noriyuki Sasaki
Mitsuo Mizumura
Original Assignee
Lederle Japan Ltd
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lederle Japan Ltd, Teikoku Seiyaku Kk filed Critical Lederle Japan Ltd
Application granted granted Critical
Publication of ATE120648T1 publication Critical patent/ATE120648T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT90125524T 1989-12-25 1990-12-27 Schmerzstillendes und entzündungshemmendes pflaster. ATE120648T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1332599A JP2839164B2 (ja) 1989-12-25 1989-12-25 消炎鎮痛貼付剤

Publications (1)

Publication Number Publication Date
ATE120648T1 true ATE120648T1 (de) 1995-04-15

Family

ID=18256747

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90125524T ATE120648T1 (de) 1989-12-25 1990-12-27 Schmerzstillendes und entzündungshemmendes pflaster.

Country Status (10)

Country Link
US (1) US5116621A (de)
EP (1) EP0436217B1 (de)
JP (1) JP2839164B2 (de)
KR (1) KR0180007B1 (de)
AT (1) ATE120648T1 (de)
CA (1) CA2033122C (de)
DE (1) DE69018424T2 (de)
DK (1) DK0436217T3 (de)
ES (1) ES2070261T3 (de)
GR (1) GR3015812T3 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462744A (en) * 1989-12-01 1995-10-31 Boehringer Ingelheim Kg Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
US5902600A (en) * 1992-12-21 1999-05-11 Healthpoint, Ltd. Hydrogel polymer wound dressing
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
US5409691A (en) * 1993-10-18 1995-04-25 Swain; Dan E. Solution comprising aluminum acetate and glycerin
US5733900A (en) * 1994-04-21 1998-03-31 Hisamitsu Pharmaceutical Co., Inc. Percutaneous administration base composition and percutaneous administration medicinal composition comprising said base composition and medicine
JPH10120560A (ja) 1996-08-26 1998-05-12 Sankyo Co Ltd ロキソプロフェン含有外用製剤
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
JPH10265374A (ja) * 1997-03-24 1998-10-06 Saitama Daiichi Seiyaku Kk 外用剤組成物及びその製造方法
US20050048102A1 (en) * 1997-10-16 2005-03-03 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6211296B1 (en) 1998-11-05 2001-04-03 The B. F. Goodrich Company Hydrogels containing substances
JP4584381B2 (ja) * 1999-07-30 2010-11-17 久光製薬株式会社 フェルビナク含有貼付剤
US6698162B2 (en) * 2000-03-23 2004-03-02 Teikoku Pharma Usa, Inc. Methods of producing a terminally sterilized topical patch preparation
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 ４−ビフェニル酢酸含有貼付剤
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
TWI412570B (zh) * 2004-04-27 2013-10-21 Showa Denko Kk Adhesive for patch and method for producing the same
TWI414320B (zh) * 2004-05-13 2013-11-11 Hisamitsu Pharmaceutical Co 含有非類固醇系消炎鎮痛劑之外用經皮製劑
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
KR100867262B1 (ko) 2007-01-17 2008-11-06 대화제약 주식회사 펠비낙을 함유하는 플라스터 조성물
WO2010103844A1 (ja) * 2009-03-11 2010-09-16 興和株式会社 鎮痛・抗炎症剤含有外用剤
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
EA201991223A1 (ru) 2011-08-18 2019-10-31 Не вызывающие зависимость мукоадгезивные устройства для доставки бупренорфина
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
JP2012144562A (ja) * 2012-04-17 2012-08-02 Teikoku Seiyaku Co Ltd 貼付剤
JP5949285B2 (ja) * 2012-07-31 2016-07-06 ライオン株式会社 貼付剤
EP2968652B1 (de) 2013-03-13 2020-07-22 Avery Dennison Corporation Verbesserung von hafteigenschaften
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
EP3520783A1 (de) * 2018-01-30 2019-08-07 Nitto Denko Corporation Präparat zur transdermalen absorption
WO2022163694A1 (ja) * 2021-01-29 2022-08-04 花王株式会社 外用剤組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842168B2 (ja) * 1974-12-20 1983-09-17 トウコウヤクヒンコウギヨウ カブシキガイシヤ 局所用剤の製造方法
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
JPS60188315A (ja) * 1984-03-07 1985-09-25 Yamanouchi Pharmaceut Co Ltd グリチルレチン酸配合鎮痒プラスター
JPS60209515A (ja) * 1984-04-03 1985-10-22 Hokuriku Seiyaku Co Ltd 消炎鎮痛クリ−ム剤
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
JPH0696529B2 (ja) * 1987-03-31 1994-11-30 積水化学工業株式会社 ニトログリセリン貼付剤およびその製造方法
EP0303445A1 (de) * 1987-08-13 1989-02-15 Walton S.A. Pflaster zur transdermalen Applikation von Cleboprid
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel

Also Published As

Publication number Publication date
CA2033122A1 (en) 1991-06-26
EP0436217A3 (en) 1991-09-25
KR0180007B1 (ko) 1999-03-20
KR910011248A (ko) 1991-08-07
DK0436217T3 (da) 1995-05-01
EP0436217B1 (de) 1995-04-05
ES2070261T3 (es) 1995-06-01
US5116621A (en) 1992-05-26
JPH03193728A (ja) 1991-08-23
DE69018424D1 (de) 1995-05-11
CA2033122C (en) 2003-08-19
GR3015812T3 (en) 1995-07-31
JP2839164B2 (ja) 1998-12-16
EP0436217A2 (de) 1991-07-10
DE69018424T2 (de) 1995-09-21

Similar Documents

Publication Publication Date Title
ATE120648T1 (de) Schmerzstillendes und entzündungshemmendes pflaster.
EP1428821A8 (de) Piperidin-4-ylamine mit analgetischer Wirksamkeit
MX9308199A (es) Inhibidores de enzima.
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE60026538D1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
DE3669828D1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
EP0706373A4 (de) In liposomen verkapseltes taxol und verwendungsverfahren
PE12697A1 (es) Compuestos heterociclicos, su preparacion y su uso
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
BR9407250A (pt) Uso de uma droga tendo atividade vasodilatadora para a fabricação de um medicamento para administração transmucosal transdérmica intranasal e retal
MX9206577A (es) COMPOSICIóN FARMACEUTICA PARA INHIBIR EL CRECIMIENTO DE CELULAS TUMORALES
DE69130529D1 (de) Behandlung von erektionversagen
DE69715049D1 (de) Tranilast enthaltendes externum und verfahren zu dessen herstellung
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
ATE267583T1 (de) Arzneizubereitungen zur behandlung sexueller funktionsstörungen
SE9601395D0 (sv) New therapeutic treatment 1
BG47648A3 (en) Method for preparing of triazolyl quanolinic compounds
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
PT1140001E (pt) Composicao para tratamento de queimaduras
KR900017599A (ko) 종양 치료용 약학 조성물
NO882724D0 (no) Smertepreparat.
KR927003530A (ko) 이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EELA Cancelled due to lapse of time